Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · Real-Time Price · USD
1.800
-0.110 (-5.76%)
Feb 21, 2025, 4:00 PM EST - Market closed
Akebia Therapeutics Market Cap
Akebia Therapeutics has a market cap or net worth of $392.73 million as of February 21, 2025. Its market cap has increased by 24.08% in one year.
Market Cap
392.73M
Enterprise Value
461.90M
1-Year Change
24.08%
Ranking
Category
Stock Price
$1.80
Market Cap Chart
Since March 20, 2014, Akebia Therapeutics's market cap has decreased from $488.10M to $392.73M, a decrease of -19.54%. That is a compound annual growth rate of -1.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 392.70M | -5.26% |
| Dec 31, 2024 | 414.50M | 77.44% |
| Dec 29, 2023 | 233.60M | 120.17% |
| Dec 30, 2022 | 106.10M | -73.17% |
| Dec 31, 2021 | 395.40M | -2.30% |
| Dec 31, 2020 | 404.70M | -46.16% |
| Dec 31, 2019 | 751.70M | 138.26% |
| Dec 31, 2018 | 315.50M | -55.11% |
| Dec 29, 2017 | 702.90M | 76.17% |
| Dec 30, 2016 | 399.00M | 0.81% |
| Dec 31, 2015 | 395.80M | 67.15% |
| Dec 31, 2014 | 236.80M | -51.49% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |